Histogenics (HSGX) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts HSGX Hot Sheet
Join SI Premium – FREE
Histogenics (NASDAQ: HSGX) reported Q1 EPS of ($0.60), $0.01 worse than the analyst estimate of ($0.59).
For earnings history and earnings-related data on Histogenics (HSGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
